Back to Journals » Open Access Journal of Contraception » Volume 3

A novel medical protocol to treat uterotubal spasm during Essure hysteroscopic sterilization: a pilot study

Authors Chapa H, Venegas

Received 5 February 2012

Accepted for publication 10 April 2012

Published 20 June 2012 Volume 2012:3 Pages 27—30

DOI https://doi.org/10.2147/OAJC.S30583

Review by Single-blind

Peer reviewer comments 3


Hector O Chapa,1 Gonzalo Venegas2

1Women's Specialty Center, Dallas, TX, USA; 2Clinical Faculty, Department ObGyn Methodist Medical Center, Dallas, TX, USA

Objective: To evaluate sublingual hyoscyamine (0.125 mg) as a uterotubal spasm reliever to increase successful bilateral, first-attempt Essure microinsert placement.
Study design: Prospective cohort study as pilot clinical investigation of study medicine.
Setting: An inner-city Dallas, TX obstetrics and gynecology office practice.
Materials and methods: The study period was January 1, 2008 to July 1, 2010. Patients requesting sterilization were offered Essure under local anesthesia (office setting). Those declining were referred for operative laparoscopy. Patients accepting office sterilization were offered study participation. Study patients noted to have intraoperative uni/bilateral uterotubal spasms preventing cannulation were given one sublingual hyoscyamine (0.125 mg) tablet. Primary endpoint: spasm alleviation and successful tubal cannulation (bilaterally). Secondary endpoint: percentage of bilateral tubal occlusions documented by follow up hysterosalpingogram (12 weeks), and adverse events possibly related to medication.
Results: Within the study period, 316 patients underwent office sterilization (local anesthesia); 21 had unilateral tubal spasm preventing cannulation (6%). Spasm was relieved in 17/21 (80%) after hyoscyamine, allowing for microinsert placement. The mean time from attempted cannulation to medication was 9 minutes (8.3–10.5 minutes), and the mean time for spasm resolution was 53 seconds (49–72 seconds). At follow-up confirmation testing, all 17 who were hyoscynamine responders were found to have bilateral tubal occlusion as well as proper microinsert location. The 4/21 hyoscyamine nonresponders underwent a second unilateral attempt 48–72 hours later. Fifty percent (n = 2) had successful placement, leaving two for alternative care. Rapid pulse was reported by 1/21 (4.7%) 5 minutes postmedication.
Conclusion: Essure sterilization has a high bilateral, first-attempt success rate. Hyoscyamine may aid in spasm relief and increase single procedure, bilateral placement success rate further.

Keywords: hysteroscopic sterilization, Essure, tubal spasm, hyoscyamine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]